 Pemoline
"Pemoline" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A central nervous system stimulant used in fatigue and depressive states and to treat hyperkinetic disorders in children.
| Descriptor ID |
D010389
|
| MeSH Number(s) |
D03.383.129.462.673
|
| Concept/Terms |
Pemoline- Pemoline
- Phenylisohydantoin
- Phenoxazole
PemADD- PemADD
- Mallinckrodt Brand of Pemoline
Tradon- Tradon
- Lilly Brand of Pemoline
Cylert- Cylert
- Abbott Brand of Pemoline
|
Below are MeSH descriptors whose meaning is more general than "Pemoline".
Below are MeSH descriptors whose meaning is more specific than "Pemoline".
This graph shows the total number of publications written about "Pemoline" by people in Harvard Catalyst Profiles by year, and whether "Pemoline" was a major or minor topic of these publication.
Below are the most recent publications written about "Pemoline" by people in Profiles.
-
Lewandowski NM, Ju S, Verbitsky M, Ross B, Geddie ML, Rockenstein E, Adame A, Muhammad A, Vonsattel JP, Ringe D, Cote L, Lindquist S, Masliah E, Petsko GA, Marder K, Clark LN, Small SA. Polyamine pathway contributes to the pathogenesis of Parkinson disease. Proc Natl Acad Sci U S A. 2010 Sep 28; 107(39):16970-5.
-
Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence. Pediatrics. 2005 Jun; 115(6):e749-57.
-
Wilens TE, Hammerness PG, Biederman J, Kwon A, Spencer TJ, Clark S, Scott M, Podolski A, Ditterline JW, Morris MC, Moore H. Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2005 Feb; 66(2):253-9.
-
Spencer T, Biederman J, Wilens T. Stimulant treatment of adult attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2004 Jun; 27(2):361-72.
-
Shader RI. Drug-attributed hepatic failure: causality, risk assessment, consent, and confusion. J Clin Psychopharmacol. 2003 Dec; 23(6):533-4.
-
Bostic JQ, Biederman J, Spencer TJ, Wilens TE, Prince JB, Monuteaux MC, Sienna M, Polisner DA, Hatch M. Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short-term controlled trial. J Child Adolesc Psychopharmacol. 2000; 10(3):205-16.
-
Wilens TE, Biederman J, Spencer TJ, Frazier J, Prince J, Bostic J, Rater M, Soriano J, Hatch M, Sienna M, Millstein RB, Abrantes A. Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 1999 Jun; 19(3):257-64.
-
Biederman J. Attention-deficit/hyperactivity disorder: a life-span perspective. J Clin Psychiatry. 1998; 59 Suppl 7:4-16.
-
Nierenberg AA, Dougherty D, Rosenbaum JF. Dopaminergic agents and stimulants as antidepressant augmentation strategies. J Clin Psychiatry. 1998; 59 Suppl 5:60-3; discussion 64.
-
Sterling MJ, Kane M, Grace ND. Pemoline-induced autoimmune hepatitis. Am J Gastroenterol. 1996 Oct; 91(10):2233-4.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|